5 comments By Jim Stallard, MA, Writer/Editor   |  Wednesday, April 3, 2013 A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies. read more

Read More:
Lung Cancer Patients Will Benefit from New Molecular Testing Guideline

Scroll to Top